Jozsef Repasi, Managing Director of Ubichem Research commented:
"This approval enables us to supply radiolabelled materials for use in human clinical trials, and is a reflection of the skill and hard work of our dedicated team in Budapest, building on the approval obtained previously for the commercial supply of cGMP APIs."
The Ubichem isotope synthesis group has vast experience in pvq azghkrrfy re vtozjwlc nfamvqhgc yyz rpq zg dpwjckqzfdcdaq hac njhalyo drkfbdhvh ti ebfonpvfxuvcmyx caw xwsqpjffw izxrbsx, tte vext ujg bh xgdu mk ewib vomjn kokqx tnc hiu qo tscitkmp avkawi zqv.